Valvular heart disease is a leading cause of cardiovascular morbidity and mortality and a
major contributor of symptoms and functional disability. Knowledge of valvular heart disease …

Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life
and longevity. The epidemiology of VHD varies substantially around the world, with a …

The epidemiology of valvular heart disease (VHD) has changed dramatically over the past
50 years in developed nations. While rheumatic disease is now uncommon, a steady rise in …

In this review, we will discuss the current knowledge of heart valve disease (HVD)
epidemiology, how it has changed over time and possible future trends. There are large …

Valvular heart diseases (VHDs), as a group, are among the most predictable causes of heart
failure (HF)[1]. They are also potentially lethal, particularly among patients who have been …

Valvular heart disease is a rapidly growing cause of global cardiovascular morbidity and
mortality with diverse and evolving geographic distribution. The prevalence of rheumatic …

Background Valvular heart diseases are not usually regarded as a major public-health
problem. Our aim was to assess their prevalence and effect on overall survival in the general …

Challenges for the treatment of valvular heart disease include the growing need for effective
yet less invasive interventions and therapies to treat these progressive conditions. With the …

Background The burden of valvular heart disease (VHD) has increased significantly among
ageing populations, yet remains poorly understood in the present-day context of …

Valvular heart disease is common and its prevalence is rapidly increasing worldwide.
Effective medical therapies are insufficient and treatment was historically limited to the …